Action of lipoprotein lipase on mixed triacylglycerol/phosphatidylcholine monolayers. Activation by apolipoprotein C-II.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 6853529)

Published in J Biol Chem on May 10, 1983

Authors

P Vainio, J A Virtanen, P K Kinnunen, A M Gotto, J T Sparrow, F Pattus, P Bougis, R Verger

Articles by these authors

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA (1998) 19.64

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51

MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neuroradiol (1998) 6.13

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (2009) 5.14

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41

Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32

The bacterial porin superfamily: sequence alignment and structure prediction. Mol Microbiol (1991) 3.45

A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43

Serum cholesterol. Doing the right thing. Circulation (1993) 3.16

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01

A 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A. Nature (1991) 2.77

1-Palmitoyl-2-pyrenedecanoyl glycerophospholipids as membrane probes: evidence for regular distribution in liquid-crystalline phosphatidylcholine bilayers. Biochemistry (1985) 2.47

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology (1996) 2.23

Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20

Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect (1995) 2.20

Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature (1994) 2.18

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation (1990) 2.10

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06

Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04

Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology (1998) 2.03

Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry (1998) 2.00

Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature (1993) 2.00

Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature (1986) 1.85

Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81

Structure of the membrane-pore-forming fragment of colicin A. Nature (1989) 1.80

Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med (2000) 1.77

Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76

Structure of the pancreatic lipase-procolipase complex. Nature (1992) 1.76

Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J (2000) 1.74

Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74

Structural and functional alterations of a colicin-resistant mutant of OmpF porin from Escherichia coli. Proc Natl Acad Sci U S A (1994) 1.74

Interfacial enzyme kinetics of lipolysis. Annu Rev Biophys Bioeng (1976) 1.73

Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72

Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71

Action of phospholipase A at interfaces. J Biol Chem (1973) 1.70

Refined structure of the pore-forming domain of colicin A at 2.4 A resolution. J Mol Biol (1992) 1.70

Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69

Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68

The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem (1983) 1.67

Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology (1994) 1.67

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65

Reversibility of the binding of cytochrome c to liposomes. Implications for lipid-protein interactions. J Biol Chem (1995) 1.64

Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Chem Phys Lipids (1997) 1.64

Lateral organisation of membrane lipids. The superlattice view. Biochim Biophys Acta (1999) 1.62

Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner (1992) 1.61

Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60

Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57

The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54

Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53

Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53

AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52

Cutinase, a lipolytic enzyme with a preformed oxyanion hole. Biochemistry (1994) 1.51

The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50

Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem (1986) 1.50

Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia (1988) 1.46

The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46

Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr (1985) 1.45

An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43

Risk reduction. Circulation (2000) 1.42

Communication patterns in a biomedical research center. J Med Educ (1978) 1.42

A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med (Berl) (2000) 1.42

An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol (1991) 1.42

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem (2000) 1.42

Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry (1978) 1.41

Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40

On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging (1998) 1.39

The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun (1978) 1.39

The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39

Spreading of membranes at the air/water interface. Chem Phys Lipids (1976) 1.38

Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36

Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur J Biochem (2001) 1.36

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A (1983) 1.36

The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun (1985) 1.36

Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35

Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A (1977) 1.35

Membrane topology and site-specific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol Microbiol (1995) 1.33

A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther (1996) 1.31

Functional domains of colicin A. Mol Microbiol (1988) 1.31

Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res (1980) 1.30

Enzyme kinetics of lipolysis. Methods Enzymol (1980) 1.30

Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med (1990) 1.29

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest (1984) 1.29

Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. Proc Natl Acad Sci U S A (1999) 1.29

Evidence for the formation of microdomains in liquid crystalline large unilamellar vesicles caused by hydrophobic mismatch of the constituent phospholipids. Biophys J (1996) 1.29

Phospholipase A2 as a mechanosensor. Biophys J (1995) 1.29

Binding of cytochrome c to liposomes as revealed by the quenching of fluorescence from pyrene-labeled phospholipids. Biochemistry (1987) 1.29

The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem (1985) 1.28

Evidence for two distinct acidic phospholipid-binding sites in cytochrome c. J Biol Chem (1994) 1.27

MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. AJNR Am J Neuroradiol (2001) 1.27